Thr2095
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Thr2095  -  AlphaK2 (human)

Site Information
LtDVGIAtLAkGYKG   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 23081353

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 )
Disease tissue studied:
gastric carcinoma, surrounding tissue ( 2 )
Relevant cell line - cell type - tissue:
HeLa_Meta (cervical) ( 1 ) , HeLa_Pro (cervical) ( 1 ) , HeLa_Telo (cervical) ( 1 ) , stomach ( 2 )

Upstream Regulation
Treatments:
MG132_withdrawal ( 1 )

References 

1

Dulla K, et al. (2010) Quantitative site-specific phosphorylation dynamics of human protein kinases during mitotic progression. Mol Cell Proteomics 9, 1167-81
20097925   Curated Info

2

Ren H (2008) CST Curation Set: 5497; Year: 2008; Biosample/Treatment: tissue, gastrointestinal tract/untreated; Disease: gastric cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info